Indeed, our in depth analysis of the RAC1 signaling pathway arose from the transcriptomic data in human iPSC-derived DAn from PD patients, showing altered Rho signaling as top deregulated pathway, points to this same direction (Online Resources8–9). This evidence concerns the gene RHO and Parkinson disease.